Loading…

The Cortisol Awakening Response as a Biomarker for Cognitive Side-Effects of Electroconvulsive Therapy

•What is the primary question addressed by this study?This study examined whether the Cortisol Awakening Response (CAR) could be a biomarker for cognitive change during electroconvulsive therapy (ECT).•What is the main finding of this study?We found no significant associations between the CAR and co...

Full description

Saved in:
Bibliographic Details
Published in:The American journal of geriatric psychiatry 2023-11, Vol.31 (11), p.991-995
Main Authors: Feenstra, Thomas C., la Cruz, Eldon K.J., Obbels, Jasmien, Laroy, Maarten, Bouckaert, Filip, Sienaert, Pascal, Oudega, Mardien, Dols, Annemieke, van Exel, Eric, Beekman, Aartjan T.F., Rhebergen, Didi
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by
cites cdi_FETCH-LOGICAL-c307t-834434bfe2a7ef771458718d80b6575484c94ec95b51aa14b4e4fab99f057e563
container_end_page 995
container_issue 11
container_start_page 991
container_title The American journal of geriatric psychiatry
container_volume 31
creator Feenstra, Thomas C.
la Cruz, Eldon K.J.
Obbels, Jasmien
Laroy, Maarten
Bouckaert, Filip
Sienaert, Pascal
Oudega, Mardien
Dols, Annemieke
van Exel, Eric
Beekman, Aartjan T.F.
Rhebergen, Didi
description •What is the primary question addressed by this study?This study examined whether the Cortisol Awakening Response (CAR) could be a biomarker for cognitive change during electroconvulsive therapy (ECT).•What is the main finding of this study?We found no significant associations between the CAR and cognitive change during the ECT course in (un)adjusted models.•What is the meaning of the finding?Our results indicate that the CAR is not usable as a biomarker for ECT-induced cognitive change during the ECT course. To test whether the cortisol awakening response (CAR) could be a biomarker for cognitive decline during electroconvulsive therapy (ECT). We studied 50 older patients with depression who were treated with ECT from the MODECT cohort. We used linear regression analyses to examine the association between CAR and cognitive change, assessed by the change in Mini Mental State Examination scores between baseline and 1 week after ECT course. CAR was assessed by the area under the curve of cortisol levels, according to Pruessner's-formula. Associations were adjusted for putative confounders, based on previous literature and availability. We found no significant associations between the CAR and cognitive change during the ECT course in (un)adjusted models. Our results indicate that the CAR is not usable as a biomarker for ECT-induced cognitive decline during ECT course. Further research in cohorts with larger samples is needed.
doi_str_mv 10.1016/j.jagp.2023.07.004
format article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2841021190</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S1064748123003494</els_id><sourcerecordid>2841021190</sourcerecordid><originalsourceid>FETCH-LOGICAL-c307t-834434bfe2a7ef771458718d80b6575484c94ec95b51aa14b4e4fab99f057e563</originalsourceid><addsrcrecordid>eNp9kE1v1DAURS1ERT_gD7BAXrJJeE6e40RiU0ZDW6lSJShry3GeB08zcbAzg_rv8WgKS1bvLs690juMvRdQChDNp225NZu5rKCqS1AlAL5iF0KiLFQl8HXO0GChsBXn7DKlLQA0XYNv2HmtUHWNggvmHn8SX4W4-BRGfv3bPNHkpw3_RmkOUyJuEjf8iw87E58ochdixjeTX_yB-Hc_ULF2juySeHB8PeYUgw3TYT-mI5Hno5mf37IzZ8ZE717uFfvxdf24ui3uH27uVtf3ha1BLUVbI9bYO6qMIqeUQNkq0Q4t9I1UElu0HZLtZC-FMQJ7JHSm7zoHUpFs6iv28bQ7x_BrT2nRO58sjaOZKOyTrloUUAnRQUarE2pjSCmS03P0-ctnLUAf_eqtPvrVR78alM5-c-nDy_6-39Hwr_JXaAY-nwDKXx48RZ2sp8nS4GN2o4fg_7f_B0cHjBM</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2841021190</pqid></control><display><type>article</type><title>The Cortisol Awakening Response as a Biomarker for Cognitive Side-Effects of Electroconvulsive Therapy</title><source>ScienceDirect</source><creator>Feenstra, Thomas C. ; la Cruz, Eldon K.J. ; Obbels, Jasmien ; Laroy, Maarten ; Bouckaert, Filip ; Sienaert, Pascal ; Oudega, Mardien ; Dols, Annemieke ; van Exel, Eric ; Beekman, Aartjan T.F. ; Rhebergen, Didi</creator><creatorcontrib>Feenstra, Thomas C. ; la Cruz, Eldon K.J. ; Obbels, Jasmien ; Laroy, Maarten ; Bouckaert, Filip ; Sienaert, Pascal ; Oudega, Mardien ; Dols, Annemieke ; van Exel, Eric ; Beekman, Aartjan T.F. ; Rhebergen, Didi</creatorcontrib><description>•What is the primary question addressed by this study?This study examined whether the Cortisol Awakening Response (CAR) could be a biomarker for cognitive change during electroconvulsive therapy (ECT).•What is the main finding of this study?We found no significant associations between the CAR and cognitive change during the ECT course in (un)adjusted models.•What is the meaning of the finding?Our results indicate that the CAR is not usable as a biomarker for ECT-induced cognitive change during the ECT course. To test whether the cortisol awakening response (CAR) could be a biomarker for cognitive decline during electroconvulsive therapy (ECT). We studied 50 older patients with depression who were treated with ECT from the MODECT cohort. We used linear regression analyses to examine the association between CAR and cognitive change, assessed by the change in Mini Mental State Examination scores between baseline and 1 week after ECT course. CAR was assessed by the area under the curve of cortisol levels, according to Pruessner's-formula. Associations were adjusted for putative confounders, based on previous literature and availability. We found no significant associations between the CAR and cognitive change during the ECT course in (un)adjusted models. Our results indicate that the CAR is not usable as a biomarker for ECT-induced cognitive decline during ECT course. Further research in cohorts with larger samples is needed.</description><identifier>ISSN: 1064-7481</identifier><identifier>EISSN: 1545-7214</identifier><identifier>DOI: 10.1016/j.jagp.2023.07.004</identifier><identifier>PMID: 37479670</identifier><language>eng</language><publisher>England: Elsevier Inc</publisher><subject>cognitive side-effects ; cortisol ; electroconvulsive therapy ; Major depressive disorder</subject><ispartof>The American journal of geriatric psychiatry, 2023-11, Vol.31 (11), p.991-995</ispartof><rights>2023 American Association for Geriatric Psychiatry</rights><rights>Copyright © 2023 American Association for Geriatric Psychiatry. Published by Elsevier Inc. All rights reserved.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c307t-834434bfe2a7ef771458718d80b6575484c94ec95b51aa14b4e4fab99f057e563</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.sciencedirect.com/science/article/pii/S1064748123003494$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,780,784,3549,27924,27925,45780</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/37479670$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Feenstra, Thomas C.</creatorcontrib><creatorcontrib>la Cruz, Eldon K.J.</creatorcontrib><creatorcontrib>Obbels, Jasmien</creatorcontrib><creatorcontrib>Laroy, Maarten</creatorcontrib><creatorcontrib>Bouckaert, Filip</creatorcontrib><creatorcontrib>Sienaert, Pascal</creatorcontrib><creatorcontrib>Oudega, Mardien</creatorcontrib><creatorcontrib>Dols, Annemieke</creatorcontrib><creatorcontrib>van Exel, Eric</creatorcontrib><creatorcontrib>Beekman, Aartjan T.F.</creatorcontrib><creatorcontrib>Rhebergen, Didi</creatorcontrib><title>The Cortisol Awakening Response as a Biomarker for Cognitive Side-Effects of Electroconvulsive Therapy</title><title>The American journal of geriatric psychiatry</title><addtitle>Am J Geriatr Psychiatry</addtitle><description>•What is the primary question addressed by this study?This study examined whether the Cortisol Awakening Response (CAR) could be a biomarker for cognitive change during electroconvulsive therapy (ECT).•What is the main finding of this study?We found no significant associations between the CAR and cognitive change during the ECT course in (un)adjusted models.•What is the meaning of the finding?Our results indicate that the CAR is not usable as a biomarker for ECT-induced cognitive change during the ECT course. To test whether the cortisol awakening response (CAR) could be a biomarker for cognitive decline during electroconvulsive therapy (ECT). We studied 50 older patients with depression who were treated with ECT from the MODECT cohort. We used linear regression analyses to examine the association between CAR and cognitive change, assessed by the change in Mini Mental State Examination scores between baseline and 1 week after ECT course. CAR was assessed by the area under the curve of cortisol levels, according to Pruessner's-formula. Associations were adjusted for putative confounders, based on previous literature and availability. We found no significant associations between the CAR and cognitive change during the ECT course in (un)adjusted models. Our results indicate that the CAR is not usable as a biomarker for ECT-induced cognitive decline during ECT course. Further research in cohorts with larger samples is needed.</description><subject>cognitive side-effects</subject><subject>cortisol</subject><subject>electroconvulsive therapy</subject><subject>Major depressive disorder</subject><issn>1064-7481</issn><issn>1545-7214</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2023</creationdate><recordtype>article</recordtype><recordid>eNp9kE1v1DAURS1ERT_gD7BAXrJJeE6e40RiU0ZDW6lSJShry3GeB08zcbAzg_rv8WgKS1bvLs690juMvRdQChDNp225NZu5rKCqS1AlAL5iF0KiLFQl8HXO0GChsBXn7DKlLQA0XYNv2HmtUHWNggvmHn8SX4W4-BRGfv3bPNHkpw3_RmkOUyJuEjf8iw87E58ochdixjeTX_yB-Hc_ULF2juySeHB8PeYUgw3TYT-mI5Hno5mf37IzZ8ZE717uFfvxdf24ui3uH27uVtf3ha1BLUVbI9bYO6qMIqeUQNkq0Q4t9I1UElu0HZLtZC-FMQJ7JHSm7zoHUpFs6iv28bQ7x_BrT2nRO58sjaOZKOyTrloUUAnRQUarE2pjSCmS03P0-ctnLUAf_eqtPvrVR78alM5-c-nDy_6-39Hwr_JXaAY-nwDKXx48RZ2sp8nS4GN2o4fg_7f_B0cHjBM</recordid><startdate>20231101</startdate><enddate>20231101</enddate><creator>Feenstra, Thomas C.</creator><creator>la Cruz, Eldon K.J.</creator><creator>Obbels, Jasmien</creator><creator>Laroy, Maarten</creator><creator>Bouckaert, Filip</creator><creator>Sienaert, Pascal</creator><creator>Oudega, Mardien</creator><creator>Dols, Annemieke</creator><creator>van Exel, Eric</creator><creator>Beekman, Aartjan T.F.</creator><creator>Rhebergen, Didi</creator><general>Elsevier Inc</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20231101</creationdate><title>The Cortisol Awakening Response as a Biomarker for Cognitive Side-Effects of Electroconvulsive Therapy</title><author>Feenstra, Thomas C. ; la Cruz, Eldon K.J. ; Obbels, Jasmien ; Laroy, Maarten ; Bouckaert, Filip ; Sienaert, Pascal ; Oudega, Mardien ; Dols, Annemieke ; van Exel, Eric ; Beekman, Aartjan T.F. ; Rhebergen, Didi</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c307t-834434bfe2a7ef771458718d80b6575484c94ec95b51aa14b4e4fab99f057e563</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2023</creationdate><topic>cognitive side-effects</topic><topic>cortisol</topic><topic>electroconvulsive therapy</topic><topic>Major depressive disorder</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Feenstra, Thomas C.</creatorcontrib><creatorcontrib>la Cruz, Eldon K.J.</creatorcontrib><creatorcontrib>Obbels, Jasmien</creatorcontrib><creatorcontrib>Laroy, Maarten</creatorcontrib><creatorcontrib>Bouckaert, Filip</creatorcontrib><creatorcontrib>Sienaert, Pascal</creatorcontrib><creatorcontrib>Oudega, Mardien</creatorcontrib><creatorcontrib>Dols, Annemieke</creatorcontrib><creatorcontrib>van Exel, Eric</creatorcontrib><creatorcontrib>Beekman, Aartjan T.F.</creatorcontrib><creatorcontrib>Rhebergen, Didi</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>The American journal of geriatric psychiatry</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Feenstra, Thomas C.</au><au>la Cruz, Eldon K.J.</au><au>Obbels, Jasmien</au><au>Laroy, Maarten</au><au>Bouckaert, Filip</au><au>Sienaert, Pascal</au><au>Oudega, Mardien</au><au>Dols, Annemieke</au><au>van Exel, Eric</au><au>Beekman, Aartjan T.F.</au><au>Rhebergen, Didi</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>The Cortisol Awakening Response as a Biomarker for Cognitive Side-Effects of Electroconvulsive Therapy</atitle><jtitle>The American journal of geriatric psychiatry</jtitle><addtitle>Am J Geriatr Psychiatry</addtitle><date>2023-11-01</date><risdate>2023</risdate><volume>31</volume><issue>11</issue><spage>991</spage><epage>995</epage><pages>991-995</pages><issn>1064-7481</issn><eissn>1545-7214</eissn><abstract>•What is the primary question addressed by this study?This study examined whether the Cortisol Awakening Response (CAR) could be a biomarker for cognitive change during electroconvulsive therapy (ECT).•What is the main finding of this study?We found no significant associations between the CAR and cognitive change during the ECT course in (un)adjusted models.•What is the meaning of the finding?Our results indicate that the CAR is not usable as a biomarker for ECT-induced cognitive change during the ECT course. To test whether the cortisol awakening response (CAR) could be a biomarker for cognitive decline during electroconvulsive therapy (ECT). We studied 50 older patients with depression who were treated with ECT from the MODECT cohort. We used linear regression analyses to examine the association between CAR and cognitive change, assessed by the change in Mini Mental State Examination scores between baseline and 1 week after ECT course. CAR was assessed by the area under the curve of cortisol levels, according to Pruessner's-formula. Associations were adjusted for putative confounders, based on previous literature and availability. We found no significant associations between the CAR and cognitive change during the ECT course in (un)adjusted models. Our results indicate that the CAR is not usable as a biomarker for ECT-induced cognitive decline during ECT course. Further research in cohorts with larger samples is needed.</abstract><cop>England</cop><pub>Elsevier Inc</pub><pmid>37479670</pmid><doi>10.1016/j.jagp.2023.07.004</doi><tpages>5</tpages></addata></record>
fulltext fulltext
identifier ISSN: 1064-7481
ispartof The American journal of geriatric psychiatry, 2023-11, Vol.31 (11), p.991-995
issn 1064-7481
1545-7214
language eng
recordid cdi_proquest_miscellaneous_2841021190
source ScienceDirect
subjects cognitive side-effects
cortisol
electroconvulsive therapy
Major depressive disorder
title The Cortisol Awakening Response as a Biomarker for Cognitive Side-Effects of Electroconvulsive Therapy
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-29T00%3A38%3A05IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=The%20Cortisol%20Awakening%20Response%20as%20a%20Biomarker%20for%20Cognitive%20Side-Effects%20of%20Electroconvulsive%20Therapy&rft.jtitle=The%20American%20journal%20of%20geriatric%20psychiatry&rft.au=Feenstra,%20Thomas%20C.&rft.date=2023-11-01&rft.volume=31&rft.issue=11&rft.spage=991&rft.epage=995&rft.pages=991-995&rft.issn=1064-7481&rft.eissn=1545-7214&rft_id=info:doi/10.1016/j.jagp.2023.07.004&rft_dat=%3Cproquest_cross%3E2841021190%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c307t-834434bfe2a7ef771458718d80b6575484c94ec95b51aa14b4e4fab99f057e563%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2841021190&rft_id=info:pmid/37479670&rfr_iscdi=true